| Erkki Ruoslahti, MD, PhD
Distinguished professor, Cancer Center, Sanford Burnham Prebys Medical Discovery InstituteLa Jolla, USA |
|
Assistant Professor of Surgery. Columbia University, New York, USA |
|
Professor, Nanomedicine and Theranostics group, University of Aachen, Germany |
|
Professor & Chief Surgeon, School of Medicine, University of Tampere, Tampere, Finland |
| Hélder A. Santos, PhD
Professor of Biomedical Engineering, University of Groningen, Netherlands |
|
Academy of Finland Research Fellow, Department of Virology, University fo Helsinki, Finland |
| Cyrus Safinya, PhD
Professor, Materials Research Laboratory, University of California, Santa Barbara, USA |
|
Royal Society Noreen Murray Research Professor, School of Biochemistry, University of Bristol, UK |
| Dinorah Friedmann-Morvinski, PhD Professor, Department of Biochemistry and Molecular Biology, Unievrsity fo Tel Aviv, Israel |
|
Professor of Microbiology and Immunology, University of Maryland, Baltimore, USA |
We use in vivo peptide phage display screens to identify homing peptides that bind to specific targets in the vasculature. Corresponding synthetic peptides are explored for targeting drugs, biologicals, and nanoparticles into tumors to increase their therapeutic index. Our laboratory is involved in preclinical and clinical efforts on development of peptide-guided diagnostic agents and therapeutics for the early detection and precision treatment of solid tumors (glioblastoma, and breast, prostate, ovarian, prostate, and colorectal carcinoma), and for precision targeting of neurological diseases.
People Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat
